Evidence map›Paper›PMID 42769612›Full record

ArticleInternational journal of genomics2026

Comprehensive and Combined Omics Analysis Reveals Immune-Infiltration-Associated Alternative Splicing and RBP Regulators Contributing to Ischemia-Reperfusion Injury in Liver Transplantation.

Bincheng Gui, Hanfei Huang

Abstract read
In one paragraph

Article in International journal of genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bincheng GuiDepartment of Organ Transplantation, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China, kmmc.cn.ORCID https://orcid.org/0009-0000-3745-8494
Hanfei HuangDepartment of Organ Transplantation, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China, kmmc.cn.ORCID https://orcid.org/0000-0003-3302-823X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hepatic ischemia-reperfusion injury (HIRI) is a major cause of early allograft dysfunction after liver transplantation, but its post-transcriptional regulation remains poorly understood. This study aimed to characterize alternative splicing (AS) events in HIRI and explore a potential association network involving RNA-binding proteins (RBPs), AS, and immune responses. Methods: Using the GSE151648 dataset (80 paired samples from 40 patients), we identified regulated alternative splicing (RAS) events and analyzed dynamic changes in immune cell populations. An RBP-RAS co-expression network was constructed, and single-cell data (GSE171539, one donor, three time points) were used to explore cell-type-specific expression of key RBPs in a qualitative, hypothesis-generating capacity. RBP expression changes were validated in an independent microarray cohort (GSE12720, 20 paired biopsies) and cross-validated with Human Protein Atlas liver proteomic data. Results: Mild IRI (IRI-) samples mainly exhibited alternative 5 Conclusions: This study suggests that mild and severe HIRI are associated with distinct splicing programs and that these changes are closely associated with immune microenvironment remodeling, supporting the hypothesis of an RBP-AS-immune regulatory network. These findings, in which the RBP expression changes were independently validated in an external cohort, provide a basis for generating hypotheses regarding post-transcriptional regulation in HIRI.

Indexed as

alternative splicingimmune microenvironmentischemia–reperfusion injuryliver transplantationRNA-binding proteins

Identifiers

PMID42769612
PMCPMC13592132

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.